Adam JacksonJuly 17, 2023
Compass is now moving forward with a larger phase 3 clinical program, marking the most extensive study of its kind to date.
Tag: depression
Adam JacksonJuly 17, 2023Adam JacksonMarch 14, 2023
Psychedelic clinical research firm Reunion Neuroscience Inc. (NASDAQ: REUN) is taking Mindset Pharma Inc. (OTCQB: MSSTF) to federal court over claims that the company copied its main psychedelic formula and presented it as its own invention while applying for a patent. Reunion filed a lawsuit against Mindset in the U.S. District Court for the District of […]
Adam JacksonFebruary 14, 2023
The company received approval in the Netherlands to start dosing humans with one of its compounds.
Adam JacksonJanuary 6, 2023
Atai plans to continue working with its compound despite the setback.
Adam JacksonOctober 24, 2022Canadian clinical stage drug development company, Algernon Pharmaceuticals Inc. (CSE: AGN) (OTCQB: AGNPF), has entered a clinical trial agreement with Yale University to study DMT for the treatment of depression. Algernon will provide DMT for the study in return for intellectual property rights with Yale around the clinical use of the drug. The company will […]
Dave HodesOctober 18, 2022
Mental health professionals turn to ketamine for treatment-resistant conditions.
Dave HodesSeptember 22, 2022
Researchers are comparing near-death experiences (NDE) to psychedelics-imagined “death” experiences to learn more about both.
Dave HodesSeptember 6, 2022
legitimate, medical psychedelics is gaining ground as an acceptable mental health therapy in clinical trials.
Adam JacksonAugust 24, 2022
Research provides new evidence of LSD's therapeutic ability to treat mental health issues.
Adam JacksonAugust 4, 2022
Braxia Scientific Corp. (CSE: BRAX) (OTC: BRAXF), acquired KetaMD, Inc. in a bid to expand ketamine-based psychedelic treatment for depression and other mental health challenges. The overall value of the deal is $6.2 million in a combination of common shares and convertible notes. KetaMD was founded by psychedelic pioneers Zappy Zapolin and Warren Gumpel, along with […]
Get the latest cannabis news delivered right to your inbox
Unpack the industry with the daily cannabis newsletter for business leaders.